Teva Investigational Site 3 — West Seneca, New York

Teva Investigational Site 3 is a clinical research site located in West Seneca, New York, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 3 has participated in 1 clinical trials.

Therapeutic areas: Narcolepsy.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in West Seneca

Browse all research sites in New York · View every site in West Seneca

• Novo Nordisk Investigational Site
• Southgate Medical Group, LLP
• Southgate Medical Group
• Circuit Clinical
• Pfizer Investigational Site
• Southgate Medical Group/ Southgate Medical Park
• Research Site
• Local Institution
• Buffalo Neurosurgery Group
• GSK Investigational Site
• Circuit Clinical/OB GYN Associates of WNY
• Sleep Medicine Centers

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 3?

Teva Investigational Site 3 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 3 conducted?

Teva Investigational Site 3 has 1 clinical trials on record. Their work covers Narcolepsy.

Is Teva Investigational Site 3 accredited by Crixeo Clinical Trials?

Teva Investigational Site 3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.